Anavex Life Sciences Corp (AVXL)

[Steady_T]

I do expect that. I just don't expect it to stay that high as other indications are approved. Economies of scale kick in.

Again it seems likely that Rett will be the first approved. That is a small market, a rare disease market, it will command a higher price. There is no real competition and the company can not be assured that other indications will be approved. The company needs to price assuming that Rett is the only indication that will ever generate income.

Once other indications are approved that situation changes. Just my OPINION. Missling has a much better understanding of the drug marketplace and pricing than I do.